Unafarma - Company finances
|
EUR
|
2021
From: 2021-11-09
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|
|
Financial data
|
|||||
| Sales revenue | - | - | 1,788 | 116,959 | 491,456 |
| Profit before tax | - | - | - | - | - |
| Net profit | 0 | -31 | -4,890 | -50,802 | 57,081 |
| Equity | 2,500 | 2,469 | -2,421 | -53,223 | 3,858 |
| Liabilities | 0 | 31 | 11,705 | 341,542 | 364,944 |
| Non-current assets | 0 | 0 | 0 | 125,052 | 123,641 |
| Current assets | 2,500 | 0 | 9,284 | 162,897 | 245,143 |
| Total assets | 2,500 | 0 | 9,284 | 287,949 | 368,784 |
|
Taxes paid
|
|||||
| STI taxes | - | - | - | 2,468 | - |
|
Financial indicators
|
|||||
| Revenue change y/y | - | - | - | +6441.3% | +320.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 0.0% | - | -52.7% | -17.6% | 15.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 0.0% | -1.3% | - | - | 1479.5% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | - | -273.5% | -43.4% | 11.6% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | - |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | 0.0 | - | - | 94.6 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | 1,788 | 116,959 | 256,407 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Unafarma - Social security debts
The amount of overdue SODRA debt for the company Unafarma as of the last working day is: 1,046 €
| From | To | Debt, € |
|---|---|---|
| 2026-09-05 | 2026-09-14 | 1046.41 |
| 2026-08-26 | 2026-09-02 | 1012.46 |
| 2026-08-23 | 2026-08-23 | 1012.46 |
| 2026-08-19 | 2026-08-19 | 1012.46 |
| 2026-08-16 | 2026-08-17 | 1012.46 |
| 2026-08-07 | 2026-08-14 | 1012.46 |
| 2026-08-06 | 2026-08-06 | 1020.84 |
| 2026-07-26 | 2026-08-05 | 1030.93 |
| 2026-07-23 | 2026-07-25 | 1064.88 |
| 2026-07-19 | 2026-07-22 | 1034.68 |
| 2026-07-07 | 2026-07-17 | 1054.51 |
| 2026-07-03 | 2026-07-06 | 1099.61 |
| 2026-06-11 | 2026-07-02 | 1156.93 |
| 2026-05-25 | 2026-06-08 | 1156.93 |
| 2026-05-22 | 2026-05-24 | 1199.58 |
| 2026-05-17 | 2026-05-21 | 1870.75 |
| 2026-05-03 | 2026-05-14 | 1870.75 |
| 2026-04-27 | 2026-04-29 | 1870.75 |
| 2026-04-26 | 2026-04-26 | 1843.43 |
| 2026-04-24 | 2026-04-25 | 1870.75 |
| 2026-04-23 | 2026-04-23 | 1850.08 |
| 2026-04-22 | 2026-04-22 | 1866.45 |
| 2026-04-21 | 2026-04-21 | 1880.40 |
| 2026-04-20 | 2026-04-20 | 1894.04 |
| 2026-04-10 | 2026-04-15 | 1553.44 |
| 2026-03-29 | 2026-04-09 | 1606.11 |
| 2026-03-17 | 2026-03-27 | 1606.11 |
| 2026-03-15 | 2026-03-16 | 1180.00 |
| 2026-02-18 | 2026-03-11 | 1180.00 |
| 2026-02-17 | 2026-02-17 | 804.86 |
| 2026-02-11 | 2026-02-16 | 812.46 |
| 2026-02-03 | 2026-02-10 | 816.36 |
| 2026-02-02 | 2026-02-02 | 819.01 |
| 2026-01-21 | 2026-02-01 | 828.28 |
| 2026-01-16 | 2026-01-20 | 822.73 |
| 2026-01-01 | 2026-01-15 | 282.71 |
| 2025-12-30 | 2025-12-30 | 282.71 |
| 2025-12-16 | 2025-12-29 | 323.97 |
| 2025-10-16 | 2025-10-26 | 991.94 |
| 2025-09-16 | 2025-09-25 | 991.94 |
| 2025-08-31 | 2025-08-31 | 73.12 |
| 2025-08-28 | 2025-08-29 | 77.19 |
| 2025-08-27 | 2025-08-27 | 73.12 |
| 2025-08-19 | 2025-08-26 | 77.19 |
| 2025-08-05 | 2025-08-05 | 914.75 |
| 2025-07-29 | 2025-08-04 | 953.82 |
| 2025-07-16 | 2025-07-28 | 991.94 |
| 2025-06-17 | 2025-06-30 | 991.94 |
| 2025-05-16 | 2025-06-04 | 970.04 |
| 2025-03-18 | 2025-03-26 | 688.55 |
| 2025-03-03 | 2025-03-03 | 633.13 |
| 2025-02-18 | 2025-02-26 | 633.13 |
| 2025-02-10 | 2025-02-10 | 57.73 |
| 2025-01-22 | 2025-01-27 | 57.73 |
| 2025-01-16 | 2025-01-21 | 57.04 |
| 2024-12-22 | 2024-12-31 | 57.04 |
| 2024-12-17 | 2024-12-20 | 57.04 |
| 2024-11-18 | 2024-11-25 | 57.04 |
| 2024-10-24 | 2024-10-30 | 58.20 |
| 2024-10-16 | 2024-10-23 | 57.04 |
| 2024-09-17 | 2024-10-01 | 57.04 |
| 2024-08-27 | 2024-08-29 | 8.54 |
| 2024-08-19 | 2024-08-26 | 114.90 |
| 2024-07-24 | 2024-08-18 | 57.86 |
| 2024-07-16 | 2024-07-23 | 57.04 |
| 2024-06-18 | 2024-07-01 | 57.04 |
| 2024-05-16 | 2024-06-02 | 57.04 |
| 2024-04-23 | 2024-04-29 | 57.99 |
| 2024-04-16 | 2024-04-22 | 57.04 |
| 2024-03-18 | 2024-03-25 | 57.04 |
| 2024-02-19 | 2024-02-27 | 31.12 |
| 2024-01-23 | 2024-02-01 | 119.92 |
| 2024-01-16 | 2024-01-22 | 119.26 |
| 2024-01-15 | 2024-01-15 | 63.44 |
| 2023-12-18 | 2024-01-11 | 63.44 |
| 2023-11-16 | 2023-12-17 | 7.62 |
Unafarma - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company Unafarma is: 3,935 €
| From | To | Overdue, € |
|---|---|---|
| 2026-09-01 | 2026-09-02 | 3935.08 |
| 2026-08-12 | 2026-08-31 | 3922.88 |
| 2026-08-07 | 2026-08-11 | 3916.17 |
| 2026-08-02 | 2026-08-06 | 3917.2 |
| 2026-07-26 | 2026-08-01 | 3945.02 |
| 2026-07-05 | 2026-07-25 | 4262.41 |
| 2026-06-19 | 2026-07-04 | 4255.13 |
| 2026-06-01 | 2026-06-18 | 1833.72 |
| 2026-05-28 | 2026-05-31 | 1830.63 |
| 2026-05-26 | 2026-05-27 | 3060.41 |
| 2026-05-25 | 2026-05-25 | 3114.12 |
| 2026-05-22 | 2026-05-24 | 3184.88 |
| 2026-05-20 | 2026-05-21 | 3183.22 |
| 2026-05-01 | 2026-05-19 | 3167.45 |
| 2026-04-29 | 2026-04-30 | 3165.85 |
| 2026-04-26 | 2026-04-28 | 3165.64 |
| 2026-04-24 | 2026-04-25 | 3152.53 |
| 2026-04-23 | 2026-04-23 | 3657.22 |
| 2026-04-22 | 2026-04-22 | 3659.0 |
| 2026-04-11 | 2026-04-21 | 3664.93 |
| 2026-04-10 | 2026-04-10 | 5345.93 |
| 2026-04-02 | 2026-04-09 | 5334.97 |
| 2026-03-29 | 2026-04-01 | 5326.75 |
| 2026-03-27 | 2026-03-28 | 3440.26 |
| 2026-03-24 | 2026-03-26 | 3876.97 |
| 2026-03-20 | 2026-03-23 | 3685.15 |
| 2026-03-08 | 2026-03-08 | 3419.14 |
| 2026-03-02 | 2026-03-07 | 3417.38 |
| 2026-02-27 | 2026-03-01 | 3418.82 |
| 2026-02-18 | 2026-02-26 | 4042.64 |
| 2026-02-03 | 2026-02-17 | 4110.4 |
| 2026-01-29 | 2026-02-02 | 4149.3 |
| 2026-01-27 | 2026-01-28 | 552.3 |
| 2026-01-23 | 2026-01-26 | 551.74 |
| 2026-01-20 | 2026-01-22 | 551.32 |
| 2026-01-18 | 2026-01-19 | 550.9 |
| 2026-01-17 | 2026-01-17 | 549.38 |
| 2026-01-11 | 2026-01-16 | 548.86 |
| 2025-12-05 | 2025-12-24 | 5.86 |
| 2025-12-02 | 2025-12-04 | 6.06 |
| 2025-11-21 | 2025-11-21 | 785.05 |
| 2025-11-20 | 2025-11-20 | 784.84 |
| 2025-11-15 | 2025-11-19 | 780.51 |
| 2025-08-21 | 2025-08-21 | 393.93 |
| 2025-08-13 | 2025-08-20 | 392.64 |
| 2025-05-20 | 2025-05-20 | 1246.19 |
| 2025-05-17 | 2025-05-19 | 1240.14 |
| 2025-05-05 | 2025-05-16 | 422.71 |
| 2025-05-01 | 2025-05-04 | 422.49 |
| 2025-04-30 | 2025-04-30 | 421.94 |
| 2025-04-28 | 2025-04-29 | 4112.94 |
| 2024-10-16 | 2024-10-16 | 0.29 |
| 2024-10-13 | 2024-10-15 | 47.41 |
| 2024-10-10 | 2024-10-12 | 47.39 |
| 2024-10-09 | 2024-10-09 | 108.47 |
| 2024-10-02 | 2024-10-08 | 61.47 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Unafarma, UAB (code 305933234) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In 2025, it reported revenue of €491.5K and net profit of €57.1K, giving a profit margin of 11.6%. This followed a strong recovery from 2024, when revenue was €117.0K and the company recorded a €50.8K loss, after a very small 2023 base of €1.8K revenue and a €4.9K loss. The 2025 revenue growth rate was +320.2% year on year. Balance sheet size also expanded, with total assets of €368.8K at the end of 2025, including €123.6K in long-term assets and €245.1K in short-term assets. Equity was €3.9K, while liabilities were €364.9K, leaving a very thin equity base and a high leverage position. Asset turnover was 1.33x, and revenue per employee was €491.5K. ROA was 15.5%, while the reported return on equity is influenced by the very small equity balance.